Abstract
Metabotropic glutamate receptors (mGluRs) are expressed predominantly on neurons and glial cells and are involved in the modulation of a wide range of signal transduction cascades. Therefore, different subtypes of mGluRs are considered a promising target for the treatment of various brain diseases. Previous studies have demonstrated the seizure-induced upregulation of mGluR5; however, its functional significance is still unclear. In the present study, we aimed to clarify the effect of treatment with the selective mGluR5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP) on epileptogenesis and behavioral impairments in rats using the lithium–pilocarpine model. We found that the administration of MTEP during the latent phase of the model did not improve survival, prevent the development of epilepsy, or attenuate its manifestations in rats. However, MTEP treatment completely prevented neuronal loss and partially attenuated astrogliosis in the hippocampus. An increase in excitatory amino acid transporter 2 expression, which has been detected in treated rats, may prevent excitotoxicity and be a potential mechanism of neuroprotection. We also found that MTEP administration did not prevent the behavioral comorbidities such as depressive-like behavior, motor hyperactivity, reduction of exploratory behavior, and cognitive impairments typical in the lithium–pilocarpine model. Thus, despite the distinct neuroprotective effect, the MTEP treatment was ineffective in preventing epilepsy.
Highlights
Temporal lobe epilepsy (TLE) is a severe neurological disorder, which manifests with spontaneously recurrent seizures and, in many cases, is accompanied by psychiatric comorbidities, such as depression, anxiety, psychosis, and cognitive impairment [1,2,3]
The specific aim of the present study was to clarify the impact of MTEP treatment on epileptogenesis in the rat lithium–pilocarpine model
Rats without rearing after administration of 40 mg/kg pilocarpine were excluded from the experiment
Summary
Temporal lobe epilepsy (TLE) is a severe neurological disorder, which manifests with spontaneously recurrent seizures and, in many cases, is accompanied by psychiatric comorbidities, such as depression, anxiety, psychosis, and cognitive impairment [1,2,3]. It is difficult to find a treatment for this type of epilepsy, and almost 30% of cases are resistant to drug therapy [4,5]. Since TLE is frequently the result of a primary brain injury, preventing TLE development following injury is considered an optimal therapeutic strategy for the acquired TLE [6,7]. A preventive treatment for epilepsy still does not exist [5]. Epileptogenesis refers to the sequence of events that converts the normal brain into one that can support a seizure. Seizures are thought to occur when the mechanisms that generally create a balance between excitation and inhibition are disturbed [8]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.